Curasan AG operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Curasan AG with three other
pharmaceutical manufacturers in Europe:
Nuevolution AB (publ)
sales of 21.31 million Swedish Kronor [US$2.42 million]
Erytech Pharma SA
(4.14 million Euro [US$4.44 million]
based in the United Kingdom
(£2.65 million [US$3.27 million]
of which 54%
Curasan AG reported sales of 6.94 million Euro (US$7.45 million)
December of 2016.
increase of 23.5%
versus 2015, when the company's sales were 5.62 million Euro.